NPI: 1740254648 · MISSION VIEJO, CA 92692 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 02/15/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 02/15/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,516 | $593K |
| 2019 | 10,328 | $552K |
| 2020 | 11,136 | $518K |
| 2021 | 8,521 | $332K |
| 2022 | 9,390 | $471K |
| 2023 | 5,924 | $852K |
| 2024 | 1,975 | $470K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,159 | 2,038 | $3.34M |
| A4657 | Syringe, with or without needle, each | 535 | 473 | $236K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 711 | 340 | $79K |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,014 | 639 | $58K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,089 | 1,237 | $41K |
| J1756 | Injection, iron sucrose, 1 mg | 4,825 | 1,257 | $33K |
| 82728 | 155 | 139 | $972.99 | |
| 90674 | 14 | 14 | $171.06 | |
| 83970 | 222 | 201 | $157.59 | |
| 85041 | 584 | 526 | $40.38 | |
| 83550 | 142 | 126 | $34.16 | |
| 83540 | 154 | 138 | $33.84 | |
| 85048 | 482 | 444 | $6.46 | |
| 85045 | 86 | 69 | $1.81 | |
| 0821 | 28 | 24 | $0.00 | |
| 0636 | 195 | 12 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 16 | 12 | $0.00 |
| 0250 | 145 | 13 | $0.00 | |
| 0305 | 24 | 12 | $0.00 | |
| 0634 | 210 | 16 | $0.00 |